A number of firms have modified their ratings and price targets on shares of Universal Health Services (NYSE: UHS) recently:

  • 1/31/2018 – Universal Health Services was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $135.00 price target on the stock. According to Zacks, “Universal Health has witnessed consistent growth in its revenue base on the back of solid Acute Care and Behavioral Health platforms. Over the years, acquisitions have also played a key role in building Universal Health’s growth trajectory. Although the shares have slightly underperformed the industry in a year’s time, its strong fundamentals are likely to favor the stock going forward. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.5% upward over the last 60 days. The company is, however, exposed to integration risks owing to several acquisitions. Further, its highly leveraged balance sheet is a major headwind. Based upon the operating trends and financial results during the first nine months of 2017, the company has lowered its 2017 earnings guidance.”
  • 1/30/2018 – Universal Health Services is now covered by analysts at Wells Fargo & Co. They set an “outperform” rating and a $144.00 price target on the stock.
  • 1/24/2018 – Universal Health Services was given a new $137.00 price target on by analysts at Mizuho. They now have a “buy” rating on the stock.
  • 1/22/2018 – Universal Health Services was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Universal Health’s shares have outperformed the industry in a year's time. Its inorganic growth impresses. Consistent growth in its revenue base on the back of solid Acute Care and Behavioral Health platforms also remains a positive. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 1.9% upward over the last 60 days. The company is, however, exposed to integration risks owing to several acquisitions. Further, its highly leveraged balance sheet is a major headwind. Based upon the operating trends and financial results during the first nine months of 2017, the company has lowered its 2017 earnings guidance.”
  • 1/6/2018 – Universal Health Services was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Universal Health’s shares have underperformed the industry in last three months .The company is  exposed to integration risks owing to several acquisitions. Further, its highly leveraged balance sheet is a major headwind. Based upon the operating trends and financial results during the first nine months of 2017, the company has lowered its 2017 earnings guidance. However, its inorganic growth impresses. Consistent growth in its revenue base on the back of solid Acute Care and Behavioral Health platforms also remains a positive.”
  • 1/4/2018 – Universal Health Services had its “buy” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $134.00 price target on the stock.
  • 1/3/2018 – Universal Health Services is now covered by analysts at Goldman Sachs Group Inc. They set a “buy” rating and a $137.00 price target on the stock.
  • 1/3/2018 – Universal Health Services was downgraded by analysts at Piper Jaffray Companies from an “overweight” rating to a “neutral” rating. They now have a $147.00 price target on the stock.
  • 12/26/2017 – Universal Health Services was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Universal Health’s s shares have outperformed the industry year to date. Its inorganic growth impresses. Consistent growth in its revenue base on the back of solid Acute Care and Behavioral Health platforms also remains a positive. However, the company is  exposed to integration risks owing to several acquisitions. Further, its highly leveraged balance sheet is a major headwind. Based upon the operating trends and financial results during the first nine months of 2017, the company has lowered its 2017 earnings guidance for the second time, so far this year. “
  • 12/19/2017 – Universal Health Services had its “outperform” rating reaffirmed by analysts at Credit Suisse Group AG. They now have a $135.00 price target on the stock, up previously from $125.00.

Universal Health Services, Inc. (NYSE UHS) opened at $115.28 on Monday. Universal Health Services, Inc. has a twelve month low of $95.26 and a twelve month high of $129.74. The firm has a market cap of $10,941.11, a P/E ratio of 15.84, a P/E/G ratio of 2.32 and a beta of 0.88. The company has a quick ratio of 1.16, a current ratio of 1.26 and a debt-to-equity ratio of 0.80.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Thursday, March 1st will be issued a $0.10 dividend. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $0.40 annualized dividend and a yield of 0.35%. Universal Health Services’s dividend payout ratio is currently 5.49%.

Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.

Receive News & Ratings for Universal Health Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services Inc and related companies with MarketBeat.com's FREE daily email newsletter.